R&D return rates for pharmaceutical industry 2010-2017 worldwide

This statistic displays the research and development returns on late-stage portfolio in the pharmaceutical industry between 2010 and 2017. The mean-extension cohort return rate was 17 percent in 2013-2015, which decreased to 12.6 percent in 2015-17 worldwide.

Research and development returns on late-stage portfolio for the global pharmaceutical industry between 2010 and 2017

Mean extension cohortMean original cohort
2010-2012-8.4%
2011-2013-6.7%
2012-2014-6%
2013-201517%5%
2014-201614.1%4.8%
2015-201712.6%3.7%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2018

Region

Worldwide

Survey time period

2010 to 2017

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical market in Italy"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.